The plaintiff in a whistleblower lawsuit against Biotronik only gets one bite at the apple, a federal appeals court ruled last week in tossing the False Claims Act suit. The U.S. Court of Appeals for the Ninth Circuit upheld the dismissal of the second lawsuit brought by Max Bennett, a former Biotronik employee who alleged that the […]
The whistleblower behind a decade-old lawsuit against Abbott (NYSE:ABT) lost his bid for a new trial after a federal appeals court this week denied his appeal. Former Guidant sales rep Kevin Colquitt sued Abbott, Johnson & Johnson (NYSE:JNJ) and Boston Scientific (NYSE:BSX) in 2006 for $219.4 million, claiming that they marketed the use of biliary stents to treat peripheral artery disease. (The magistrate overseeing the lawsuit, […]
A 10-year-old whistleblower lawsuit filed by a former Abbott (NYSE:ABT) sales rep, over the alleged off-label marketing of biliary stents, finally went to trial in Dallas yesterday. Plaintiff Kevin Colquitt, a former rep for Abbott’s Guidant division, sued Abbott, Johnson & Johnson (NYSE:JNJ) and Boston Scientific (NYSE:BSX) in 2006, claiming that they marketed the use of biliary stents to treat peripheral artery disease. (The magistrate overseeing […]
A former Unilife (NSDQ:UNIS) employee who accused the company and its management of misleading investors withdrew a whistleblower lawsuit, apologized for ever filing it and agreed to pay an unspecified amount to settle a counter-claim, the company said today. Talbot Smith, Unilife’s former vice president of integrated supply chain, accused the drug delivery device maker and its senior managers […]
A former sales rep for Covidien‘s vascular business accused the company of wrongful termination after it fired him for blowing the whistle to the FBI on an alleged kickbacks scheme.
Federal prosecutors yesterday said Biotronik agreed to pony up $4.9 million, but admitted no wrongdoing, to settle allegations that it ran a kickbacks scheme to induce physicians to use its cardiac rhythm management devices.